This test is most useful if any of these apply to you.
Diarrhea after raw seafood, swallowed lake or river water, or travel can have several causes. Plesiomonas shigelloides is one of them. Some routine stool cultures don't specifically look for it, so molecular testing can help investigate an illness that remains unexplained. Finding its DNA in your stool supports a possible diagnosis, but doesn't establish by itself that the bacterium is causing your symptoms.
This test uses quantitative PCR, or qPCR, to detect and estimate P. shigelloides DNA in a stool sample. The method repeatedly copies a selected DNA sequence and measures the resulting signal. Your report expresses the result in CFU/g stool. CFU stands for colony-forming units, a unit conventionally used when living bacteria are grown in culture. Here, the result comes from a DNA assay, so it isn't a direct count of living bacteria. Its relationship to a culture count depends on the laboratory's calibration.
Detection of this organism has an established clinical role on validated infectious-diarrhea panels. Interpreting its stool quantity as a measure of severity or a treatment target remains exploratory. The cited studies do not establish a CFU/g threshold for this assay that separates symptomatic infection from carriage, predicts spread outside the gut, or confirms recovery.
Symptoms often begin within two days of exposure. Watery diarrhea and abdominal cramps are common, sometimes with fever, nausea, or vomiting. Some infections cause blood or mucus in the stool, and prolonged illness has been reported. Most uncomplicated intestinal infections resolve on their own.
The bacterium lives in aquatic environments, including fresh water and estuaries, and can occur in fish and shellfish. Human investigations have linked infection to raw shellfish, untreated water, and international travel. It occurs worldwide, with higher detection rates reported in some studies from Southeast Asia and Africa. Those patterns vary with local conditions, the people tested, and the methods used.
Asymptomatic carriage occurs, but its frequency differs substantially between settings. A study collected one stool sample each from 204 healthy adults in Ningbo, China, across four seasons and detected P. shigelloides by PCR in about one in ten. The participants weren't followed with repeated samples for a year, and the findings don't establish how common carriage is in other communities.
Other organisms can complicate interpretation. In one BioFire stool PCR study, 16 of the 18 P. shigelloides-positive samples also contained another potential pathogen. That proportion isn't universal: a culture-based study in southeast China found P. shigelloides alone in most affected outpatients. The population and the range of organisms a panel searches for both influence how often multiple detections occur.
A culture-based case-control study in rural Ecuador found no clear association between P. shigelloides alone and diarrhea, while detection together with rotavirus was associated with diarrhea. These studies concern the organism's presence in stool. They don't validate a numerical qPCR result for deciding which organism caused an individual illness.
Rare infections outside the intestine include bloodstream infection, meningitis, eye infection, gallbladder infection, and bone infection. Published cases often involve newborns, weakened immunity, iron overload, or an absent spleen, although serious infections have also occurred in otherwise healthy adults. These diagnoses come from investigations of blood or the affected site; stool qPCR doesn't diagnose infection elsewhere in the body.
A 2026 review identified six deaths among 22 published case reports of P. shigelloides bloodstream infection. That describes a small, selected group with invasive disease. It cannot estimate the risk of death or bloodstream spread for someone with a positive stool result.
P. shigelloides can grow on several ordinary stool-culture media. Special plates aren't always necessary. It can still be overlooked because its colonies may be small, other bacteria are present, and some laboratories don't routinely identify or report it.
Molecular panels can detect infections missed by culture. Studies of BioFire, QIAstat-Dx, and BD Max evaluated detection of this organism using specific assays and specimen procedures. Some evaluations supplemented rare clinical positives with archived samples or samples containing added bacteria. Their accuracy estimates cannot be transferred to every stool qPCR assay, and they don't validate this test's CFU/g quantity as a measure of illness.
Culture provides a living isolate that can be tested against antibiotics. This qPCR result identifies bacterial DNA and does not provide antibiotic susceptibility. A negative culture can occur despite a positive molecular result, including when there are few viable organisms or antibiotics have already been taken.
Evidence-backed interventions that affect your Plesiomonas Shigelloides level
Plesiomonas Shigelloides is best interpreted alongside these tests.
An at-home stool and urine test integrating microbiome balance, pathogens, digestion, permeability, immune activity, gut metabolites, and neurotransmitter patterns to clarify what is driving bloating, food reactions, fatigue, brain fog, and mood shifts.